ICD-10-PCS Billable Code

C71NYZZ

Planar Nuclear Medicine Imaging Lymphatics, Upper Extremity to None with None, Other Radionuclide Approach

Procedural Specifications

Clinical Axis Detail Definition
SectionC Nuclear Medicine
Body System7 Lymphatic and Hematologic System
Operation1 Planar Nuclear Medicine Imaging
Body PartN Lymphatics, Upper Extremity
ApproachY Other Radionuclide
DeviceZ None
QualifierZ None

Operation Definition

Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions

Procedure Overview

Planar nuclear medicine imaging of the lymphatic and hematologic system covers single-plane scans that track how a radioactive tracer moves through lymph channels and nodes, or how it distributes through components of the blood. The best-known example is lymphoscintigraphy, in which a small dose of tracer is injected near a tumor site or in tissue and a gamma camera follows its path as it drains into nearby lymph nodes.

This type of imaging is used heavily in cancer surgery planning, particularly for breast cancer and melanoma, to identify the sentinel lymph node - the first node a tumor would drain to - so a surgeon can remove and biopsy that specific node rather than a wider group of nodes. It is also used to evaluate lymphedema, a condition where fluid builds up because lymph vessels are blocked or not draining properly, by showing where the flow of tracer slows or stops.

Anatomy & Axis Detail

Lymphatics, Upper Extremity

Lymphatics of the upper extremity drain the arm and hand through channels that largely converge on the axillary nodal basin, and this pathway is commonly imaged to evaluate lymphedema following breast cancer treatment or axillary lymph node dissection, where impaired lymphatic flow causes chronic arm swelling. Tracer injected in the hand or forearm is tracked as it ascends toward the axilla, with delayed transit, dermal backflow, or absent nodal uptake indicating disrupted lymphatic function at a particular level. This imaging can also support sentinel node mapping for upper extremity melanoma, and because axillary surgery and radiation are common causes of secondary lymphedema in this region, the study often serves to characterize the severity and pattern of an already suspected lymphatic impairment rather than to screen for an unknown one.

Radionuclide: Other Radionuclide

Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.

Coding & Documentation

The clinical note should specify the injection site, the substance traced, and confirm that the images acquired were flat, single-plane pictures. Sentinel node mapping studies are frequently paired with a same-day surgical excision, and coders need to capture the imaging and the surgical removal as separate procedures even though they are clinically linked. A common mistake is failing to distinguish a lymphatic mapping study from a general blood-pool or marrow imaging study, since both fall under the same body system in the classification but represent very different clinical targets.

Commonly Confused With

This family is frequently confused with Tomographic Nuclear Medicine Imaging of the same body system, which produces three-dimensional images rather than flat ones and is often used for spleen or bone marrow studies rather than lymph node mapping; the report's description of the acquisition technique settles which applies. It is also sometimes confused with sentinel node biopsy itself, which is a separate excision procedure coded outside of Nuclear Medicine even when performed immediately after the imaging study that located the node.